| Autor: |
Janeway KA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA., Gros L; Vall d'Hebron Research Institute and Department of Pediatric Hematology and Oncology, Vall d'Hebron University Hospital, Barcelona, Spain., Schwartz S; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität and Humboldt-Universität zu Berlin, Campus Benjamin Franklin, Berlin, Germany., Daugherty C; BTG International Inc., Conshohocken, PA, USA., Gallardo E; Protherics Medicines Development Ltd., London, UK., Hill C; BTG International Inc., Conshohocken, PA, USA., Thomas E; Protherics Medicines Development Ltd., London, UK., Ward S; BTG International Inc., Conshohocken, PA, USA., Rizzari C; Unit of Pediatrics, Foundation IRCCS San Gerardo dei Tintori, Monza, Italy.; Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy. |
Plný text